Full Press Release Details
Accuray President and Chief Executive Officer Suzanne Winter to Take
Temporary Medical Leave of Absence
MADISON, Wis., September 3, 2024 Accuray Incorporated (NASDAQ: ARAY) announced today that President and Chief Executive Officer Suzanne Winter
will be taking a temporary medical leave of absence to receive care for a treatable form of cancer, effective immediately. Accuray Senior Vice President and Chief Commercial Officer Sandeep Chalke will serve as the interim CEO during
Ms. Winter s absence. To ensure that Mr. Chalke and the organization have the necessary support, the company has formed an Executive Committee of the Board of Directors, consisting of Joseph Whitters, Chairman of the Accuray Board,
and Anne Le Grand, Chair of the Science and Technology Committee, that will advise Mr. Chalke in his interim capacity.
incredible company whose mission is to conquer cancer, I remain grateful for how far the industry has come in overcoming this disease, including the development of advanced diagnostic tools that can detect it in early stages. I go into my treatment
program extremely knowledgeable and able to advocate for the care I need, said Suzanne Winter, President and CEO of Accuray.
in the thoughts of the Board and the global Accuray organization while she takes time to prioritize her health, said Joseph Whitters, Chairman of the Board at Accuray. In the interim, the Board and I are extremely confident in Sandeep
and the strong leadership team that Suzanne has built. I am certain that they are well positioned to continue delivering on the organization s vision and strategic priorities while concurrently running day-to-day operations.
Mr. Chalke joined Accuray in May 2022 bringing more than 30 years of medical
device expertise in commercialization, business development and operations. In his role at Accuray, he has responsibility for the global commercial function, including the organization s sales, service and operations teams.
Accuray Incorporated is committed to expanding the powerful potential of radiation therapy to improve as many lives as possible. We invent unique,
market-changing solutions that are designed to deliver radiation treatments for even the most complex cases while making commonly treatable cases even easier to meet the full spectrum of patient needs. We are dedicated to continuous
innovation in radiation therapy for oncology, neuro-radiosurgery, and beyond, as we partner with clinicians and administrators, empowering them to help patients get back to their lives, faster. Accuray is headquartered in Madison, Wisconsin, with
Investor Relations, ICR-Westwicke
Public Relations Director, Accuray